A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1043 in Healthy Adult Participants Living with Overweight and/or Obesity.

Trial Identifier:	D9740C00001
Sponsor:	AstraZeneca
Collaborator:	Parexel
Start Date:	March 2026
Primary Completion Date:	March 2027
Study Completion Date:	October 2027
Condition:	Obesity

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
GB	Harrow, GB, HA1 3UJ
US, CA	Glendale, CA, US, 91206

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.